PROVETOP

Mouse CLEC9A Protein

Catalog No: CLEC9A-MF001

Species
Mouse
Expression System
HEK293
Tag
an hFc (IgG1)

Product overview

Recombinant Mouse CLEC9A Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the N-terminus. It contains amino acid residues Lys57-Ile264 (accession: NP_001192292.1).

Product Details

Molecular Aliases
CD370; CLEC9A; 9830005G06Rik; DNGR-1; HEEE9341; UNQ9341;DNGR1
Protein Length
Lys57-Ile264
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 50.9 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
CLEC9A-MF001 Bis-Tris-PAGE-white result

Mouse CLEC9A on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
CLEC9A-MF001 SEC-HPLC result

The purity of Mouse CLEC9A is greater than 95% as determined by SEC-HPLC.

Background

CLEC9A is a recently discovered C-type lectin receptor involved in sensing necrotic cells. In humans, this receptor is selectively expressed by BDCA3(+) myeloid dendritic cells (mDCs), which have been proposed to be the main human cross-presenting mDCs and may represent the human homologue of murine CD8(+) DCs. In mice, it was demonstrated that antigens delivered with antibodies to CLEC9A are presented by CD8(+) DCs to both CD4(+) and CD8(+) T cells and induce antitumor immunity in a melanoma model.

References

  1. Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M, Adema GJ, Brown GD, Figdor CG, de Vries IJ. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood. 2012 Mar 8;119(10):2284-92. doi: 10.1182/blood-2011-08-373944. Epub 2012 Jan
  2. PMID:
  3. Note: HPLC results always come from liquid protein, due to absorption peak interference of trehalose in lyophilized powder.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support